期刊文献+

甲状腺病变组织中端粒酶活性的测定及其意义

DETECTION OF TELOMERASE ACTIVITY IN THYROID LESION AND ITS SIGNIFICANCE
下载PDF
导出
摘要 目的 了解几种常见甲状腺病变组织中端粒酶活性的区别。方法 用端粒重复序列扩增法测定 1 9例甲状腺癌、1 5例甲状腺癌癌旁组织、2 1例甲状腺腺瘤、1 7例结节性甲状腺肿及 1 3例正常甲状腺组织端粒酶的活性。结果  94.74% ( 1 8/1 9)的甲状腺癌表达出端粒酶活性 ,与癌旁组织 ( 6 .6 7% )、甲状腺腺瘤 ( 4 .6 7% )、结节性甲状腺肿 ( 0 % )及正常甲状腺组织 ( 0 % )比较 ,差异均有显著性意义 (P<0 .0 0 0 1 )。结论 端粒酶是甲状腺癌定性的良好标志物 ,且在甲状腺病变的鉴别诊断中具有重要意义。 Objective To study the difference of telomerase activity in the common thyroid lesions . Methods The telomerase activity was detected in 19 patients with thyroid carcinomas, 15 samples adjacent to thyroid carcinomas,21 specimens of thyromas, 17 cases of nodular goiters and 13 pieces of normal thyroid tissues by telomeric repeat amplification protocol(TRAP). Results Eighteen of 19 samples of thyroid carcinoma, 1 of 15 samples adjacent to the cancer and 1 of 21 adenoma of the thyroid specimens showed positive telomerase activity, all 17 cases of nodular goiters and 18 samples of normal thyroid tissues exhibited negative telomerase activity, and the rate of positive telomerase activity of thyroid carcinomas was significantly higher than that of the other tissues ( P <0.0001). Conclusion The telomerase is an important qualitative marker of thyroid carcinoma and a useful index in differential diagnosis of thyroid lesions.
出处 《中国普外基础与临床杂志》 CAS 2001年第5期313-314,共2页 Chinese Journal of Bases and Clinics In General Surgery
关键词 甲状腺病变 端粒酶 端粒 重复序列扩增 Thyroid lesions Telomerase Telomeric repeat amplification protocol
  • 相关文献

参考文献9

  • 1[1]Kim NW, Piatyszek MA, Prowae KR, et al. Specific association of human telomerase activity with immortal cells and cancer [J]. Science, 1994; 266(5193) ∶ 2011
  • 2[2]Hiyama E, Hiyama K, Yokoyama T, et al. Telomerase activity in small-cell and non-small-cell lung cancers [J]. J Natl Cancer Inst, 1995; 87(12) ∶ 895
  • 3[3]Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinoma [J]. Cancer Res, 1995; 55(13) ∶ 2734
  • 4[4]Hiyama E, Gollahan L, Kataoka T, et al. Telomerase activity in human breast tumors [J]. J Natl Cancer Inst, 1996; 88(2) ∶ 116
  • 5[5]Langford LA, Piatyszek MA, Xu R, et al. Telomerase activity in human brain tumors [J]. Lancet, 1995; 346(8985) ∶ 1267
  • 6[6]Hiyama E, Youkyama T, Kuni N, et al. Telomerase activity in gastric cancer [J]. Cancer Res, 1995; 55(15) ∶ 3258
  • 7[7]Koyanagi K, Ozawa S, Ando N, et al. Clinical significance of telomerase activity in noncancerous epithelial region of esophageal squamous cell carcinoma [J]. Br J Surg, 1999; 86(5) ∶ 674
  • 8[8]Koyanagi K, Ozawa S, Ando N,et al. Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus [J].Cancer,2000; 88(7) ∶ 1524
  • 9[9]Hiyama E, Saeki T, Hiyama K, et al. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples [J]. Cancer, 2000; 90(4) ∶ 2358

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部